# Trausim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/trausim

- Industry: Healthcare Specialists
- Headquarters: Changzhou, China
- Website: www.trausim.com
- Total disclosed funding: $14M
- Latest round: Series A (Nov 8, 2022)
- Investors on record: 2

## About

Based in Changzhou, China, and established in 2010, Trausim operates as a dental equipment supplier that provides oral implant restoration solutions. The company is the subsidiary of Fulong Holdings. Its product has obtained the U.S. FDA 510(k) certification and the EU CE certification. In 2015, Trausim promoted gingival level (TL) dental implant system products.

The company provides dental implants for implantologists and patients with missing teeth to dental prothetics. It adopts equipments and surface treatment technologies. Its products and solutions include BL implant systems, TL implant systems, advanced platelet rich fibrin, surgical cassette and surgical instruments. BL implant systems include dental implant, closure screw, healing cap, abutment and impression components. Surgical cassette includes truasim surgical cassette, surgical guide cassette and sinus lift kit.

## Funding rounds

- Series A, Nov 8, 2022, $14M — MF Capital, Sunhope Capital

## Investors

- MF Capital (https://capitalatlas.ai/funds/mf-capital) — Series A
- Sunhope Capital (https://capitalatlas.ai/funds/sunhope-capital) — Series A